GSK Discontinues Leucovorin Again
Why it matters: GSK's discontinuation of leucovorin impacts patients relying on this specific chemotherapy adjunct.
- GSK is discontinuing leucovorin, a chemotherapy drug, for the second time.
- Morning Rounds also covered a revised ACIP charter.
- Morning Rounds further reported on sports betting and gambling addiction, linking it to health news.
GSK is discontinuing leucovorin, a drug used in chemotherapy, for the second time, as part of broader health news updates from Morning Rounds. This decision is highlighted alongside discussions on a revised ACIP charter and the public health implications of sports betting and gambling addiction.
